Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children

Thomas Remer1, Christiane Maser-Gluth, Kai R Boye

  • 1Department of Nutrition and Health, Research Institute of Child Nutrition, Dortmund, Germany. remer@fke-do.de

Steroids
|April 18, 2006
PubMed

Insights

Type 1 diabetes mellitus in children shows an exaggerated adrenarche, indicated by elevated urinary steroid markers. Cortisol inactivation is reduced, suggesting potential links to hyperandrogenic symptoms in female patients.

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Metabolic Disorders

Background:

  • Steroid metabolism is reportedly dysregulated in Type 1 diabetes mellitus (T1DM).
  • Adrenarche, the maturation of the adrenal gland, may be affected by T1DM and its treatment.

Purpose of the Study:

  • To non-invasively examine cortisol metabolism in children with T1DM.
  • To test if adrenarche is affected in children with T1DM under intensive insulin therapy.

Main Methods:

  • Gas chromatography-mass spectrometry profiling of urinary steroids in 109 children with T1DM (aged 4-18 years).
  • Quantification of urinary free cortisol (UFF) and cortisone (UFE) using RIA.
  • Assessment of enzyme activities (5alpha-reductase, 11beta-HSD2) via metabolite ratios, compared to 400 healthy controls.

Main Results:

  • Elevated urinary markers of adrenarche (dehydroepiandrosterone metabolites) and 6beta-hydroxycortisol, UFE, and 11beta-HSD2 activity in T1DM patients.
  • Normal overall cortisol secretion but reduced 5alpha-reductase activity.
  • Evidence of exaggerated adrenarche and reduced cortisol inactivation in T1DM children.

Conclusions:

  • T1DM in children is associated with exaggerated adrenarche, potentially explaining hyperandrogenic symptoms in females.
  • Reduced cortisol inactivation via 5alpha-reductase is not compensated by decreased cortisol secretion.
  • Elevated urinary 6beta-hydroxycortisol and cortisone warrant further investigation as potential non-invasive clinical stress markers.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...